Mivacurium and bronchospasm.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12873940.
- Also identified by DOI 10.1213/01.ANE.0000067433.05538.3D.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Because of case reports of severe bronchospasm after the use of mivacurium, we used the Food and Drug Administration MedWatch database to determine the frequency of bronchospasm as an adverse event after the use of nondepolarizing muscle relaxants.
Medical subject headings
- Bronchial Spasm
- Isoquinolines
- Neuromuscular Nondepolarizing Agents